Jan 7, 2014

Posted by in Featured, Stock Market News | 0 Comments

Stocks Gaining Momentum: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Epizyme Inc (NASDAQ:EPZM), IsoRay, Inc. (NYSEMKT:ISR), Westport Innovations Inc. (USA) (NASDAQ:WPRT)

Stocks Gaining Momentum: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Epizyme Inc (NASDAQ:EPZM), IsoRay, Inc. (NYSEMKT:ISR), Westport Innovations Inc. (USA) (NASDAQ:WPRT)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) made a new 52-week high of $16.89 in the current trading session after the company announced positive results of its Phase II study for the treatment of people suffering from tardive dyskinesia. NBIX shares are trading in the range of $15.20 to $16.89 today. The company has a market capitalization of $1.13 billion.

Epizyme Inc (NASDAQ:EPZM) jumped 70.24 percent to $34.90 today on volume of 1.34 million shares.  The biopharmaceutical announced on Monday that its chief executive officer, Robert J. Gould will participate in the 32nd Annual J.P. Morgan Healthcare Conference on 16th of January at 12 p.m. PST. EPZM stock has a 52-week range of $18.10 to $45.72. The company has a market capitalization of $981.60 million.

IsoRay, Inc. (NYSEMKT:ISR) rose 10.33 percent to $0.582, on volume of 2.06 million shares, in the current trading session. The 52-week range of the stock is $0.42 to $0.85. ISR shares have been moving up from the last few days. The stock increased more than 17 percent in the past five days. The company has a market capitalization of $22.36 million.

Westport Innovations Inc. (USA) (NASDAQ:WPRT) is currently trading at $22.00 on volume of 1.37 million shares. The 52-week range of the stock is $17.07 to $35.40. Westport Innovations is engaged in offering engine and fuel system technologies using gaseous fuels. Its products and technology allows petroleum-based fuel engines to utilize natural gas and alternative fuels. The company has a market capitalization of $1.27 billion.

Comments are closed.